Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ofei, F.
Right arrow Articles by Taylor, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ofei, F.
Right arrow Articles by Taylor, R.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 7 881-885, Copyright © 1996 by American Diabetes Association

ARTICLES

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM

F Ofei, S Hurel, J Newkirk, M Sopwith and R Taylor
Human Metabolism Research Centre, Medical School, University of Newcastle, Newcastle upon Tyne, UK.

Inhibition of tumor necrosis factor (TNF)-alpha action has recently been shown to reverse insulin resistance dramatically and to improve glycemic control in obese rodents. This double-blind study was designed to assess the effects of a recombinant-engineered human TNF-alpha-neutralizing antibody (CDP571) on glucose homeostasis in obese NIDDM patients. Glycemic control and insulin sensitivity were monitored in 21 NIDDM subjects for a 2-week run-in and then for 6 weeks after treatment in a randomized fashion with a single intravenous dose of either CDP571 (5 mg/kg) or an equivalent volume of normal saline. The prolonged half-life of the antibody ensured adequate plasma levels as measured throughout the study. Concentrations of fasting glucose (CDP571: 10.0 +/- 0.8, 10.1 +/- 0.8, 10.0 +/- 1.0; placebo: 8.5 +/- 0.6, 8.1 +/- 0.5, 8.7 +/- 0.8 mmol/l at baseline, day 1, and week 4, respectively), fasting serum insulin (CDP571: 21.2 +/- 2.8, 21.0 +/- 2.8, 24.8 +/- 3.3; placebo: 19.0 +/- 2.8, 20.8 +/- 2.9, 17.5 +/- 2.2 pmol/l, respectively), and C-peptide remained unaffected by the type of treatment throughout the study. The percentage rate of glucose clearance per minute (KITT) during intravenous insulin sensitivity tests was identical in the CDP571 and placebo groups at baseline and also at 1 and 4 weeks after treatment (mean +/- SE; CDP571: 1.33 +/- 0.21, 1.44 +/- 0.25, 1.26 +/- 0.18; placebo: 1.38 +/- 0.15, 1.47 +/- 0.20, 1.52 +/- 0.20; P = 0.85, 0.93, and 0.36, respectively). TNF-alpha neutralization over a period of 4 weeks had no effect on insulin sensitivity in obese NIDDM subjects.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
N. Rasouli and P. A. Kern
Adipocytokines and the Metabolic Complications of Obesity
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s64 - s73.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. E. Mallewa, E. Wilkins, J. Vilar, M. Mallewa, D. Doran, D. Back, and M. Pirmohamed
HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options
J. Antimicrob. Chemother., October 1, 2008; 62(4): 648 - 660.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Liang, B. Yin, H. Zhang, S. Zhang, Q. Zeng, J. Wang, X. Jiang, L. Yuan, C.-Y. Wang, and Z. Li
Blockade of Tumor Necrosis Factor (TNF) Receptor Type 1-Mediated TNF-{alpha} Signaling Protected Wistar Rats from Diet-Induced Obesity and Insulin Resistance
Endocrinology, June 1, 2008; 149(6): 2943 - 2951.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. Zu, H. Jiang, J. He, C. Xu, S. Pu, M. Liu, and G. Xu
Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-{alpha} in Primary Rat Adipocytes
Mol. Pharmacol., January 1, 2008; 73(1): 215 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Lo, L. E. Bernstein, B. Canavan, M. Torriani, M. B. Jackson, R. S. Ahima, and S. K. Grinspoon
Effects of TNF-{alpha} neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E102 - E109.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. A. Barbour, C. E. McCurdy, T. L. Hernandez, J. P. Kirwan, P. M. Catalano, and J. E. Friedman
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Diabetes Care, July 1, 2007; 30(Supplement_2): S112 - S119.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Popa, M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef
The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
J. Lipid Res., April 1, 2007; 48(4): 751 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
F. C Huvers, C. Popa, M. G Netea, F. H J van den Hoogen, and C. J Tack
Improved insulin sensitivity by anti-TNF{alpha} antibody treatment in patients with rheumatic diseases
Ann Rheum Dis, April 1, 2007; 66(4): 558 - 559.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
I C van Eijk, M J L Peters, M T Nurmohamed, A W van Deutekom, B A C Dijkmans, and S Simsek
Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis
Eur. J. Endocrinol., March 1, 2007; 156(3): 291 - 293.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. G. Boulton and J. T. Bourne
Unstable diabetes in a patient receiving anti-TNF-{alpha} for rheumatoid arthritis
Rheumatology, January 1, 2007; 46(1): 178 - 179.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. E. Trujillo and P. E. Scherer
Adipose Tissue-Derived Factors: Impact on Health and Disease
Endocr. Rev., December 1, 2006; 27(7): 762 - 778.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Krogh-Madsen, P. Plomgaard, K. Moller, B. Mittendorfer, and B. K. Pedersen
Influence of TNF-{alpha} and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E108 - E114.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon
Effects of Etanercept in Patients With the Metabolic Syndrome.
Arch Intern Med, April 24, 2006; 166(8): 902 - 908.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. T. A. Nguyen, H. Satoh, S. Favelyukis, J. L. Babendure, T. Imamura, J. I. Sbodio, J. Zalevsky, B. I. Dahiyat, N.-W. Chi, and J. M. Olefsky
JNK and Tumor Necrosis Factor-{alpha} Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
J. Biol. Chem., October 21, 2005; 280(42): 35361 - 35371.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J. R. Zierath, and B. K. Pedersen
Tumor Necrosis Factor-{alpha} Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation
Diabetes, October 1, 2005; 54(10): 2939 - 2945.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. R. Berggren, M. W. Hulver, and J. A. Houmard
Fat as an endocrine organ: influence of exercise
J Appl Physiol, August 1, 2005; 99(2): 757 - 764.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. J. Klover, A. H. Clementi, and R. A. Mooney
Interleukin-6 Depletion Selectively Improves Hepatic Insulin Action in Obesity
Endocrinology, August 1, 2005; 146(8): 3417 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
D N Kiortsis, A K Mavridis, S Vasakos, S N Nikas, and A A Drosos
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis
Ann Rheum Dis, May 1, 2005; 64(5): 765 - 766.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. B. Savage, K. F. Petersen, and G. I. Shulman
Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
Hypertension, May 1, 2005; 45(5): 828 - 833.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg
Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation
Circulation, March 22, 2005; 111(11): 1448 - 1454.
[Full Text] [PDF]

Home page
 DiabetesHome page
S. A. Summers and D. H. Nelson
A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome
Diabetes, March 1, 2005; 54(3): 591 - 602.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Kitano, K. Oda, T. Kimura, Y. Matsuoka, M. Csete, J. Doyle, and M. Muramatsu
Metabolic Syndrome and Robustness Tradeoffs
Diabetes, December 1, 2004; 53(suppl_3): S6 - S15.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
B. E. Wisse
The Inflammatory Syndrome: The Role of Adipose Tissue Cytokines in Metabolic Disorders Linked to Obesity
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2792 - 2800.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. G. Pittas, N. A. Joseph, and A. S. Greenberg
Adipocytokines and Insulin Resistance
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 447 - 452.
[Full Text] [PDF]

Home page
 DiabetesHome page
P. J. Klover, T. A. Zimmers, L. G. Koniaris, and R. A. Mooney
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Diabetes, November 1, 2003; 52(11): 2784 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Rask-Madsen, H. Dominguez, N. Ihlemann, T. Hermann, L. Kober, and C. Torp-Pedersen
Tumor Necrosis Factor-{alpha} Inhibits Insulin's Stimulating Effect on Glucose Uptake and Endothelium-Dependent Vasodilation in Humans
Circulation, October 14, 2003; 108(15): 1815 - 1821.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Krakoff, T. Funahashi, C. D.A. Stehouwer, C. G. Schalkwijk, S. Tanaka, Y. Matsuzawa, S. Kobes, P. A. Tataranni, R. L. Hanson, W. C. Knowler, et al.
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
Diabetes Care, June 1, 2003; 26(6): 1745 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Freemark
Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 3 - 13.
[Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
N. Sattar, C. G Perry, and J. R Petrie
Type 2 diabetes as an inflammatory disorder
The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 36 - 41.
[Abstract] [PDF]

Home page
 DiabetesHome page
D. Dietze, M. Koenen, K. Rohrig, H. Horikoshi, H. Hauner, and J. Eckel
Impairment of Insulin Signaling in Human Skeletal Muscle Cells by Co-Culture With Human Adipocytes
Diabetes, August 1, 2002; 51(8): 2369 - 2376.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-P. Bastard, M. Maachi, J. T. van Nhieu, C. Jardel, E. Bruckert, A. Grimaldi, J.-J. Robert, J. Capeau, and B. Hainque
Adipose Tissue IL-6 Content Correlates with Resistance to Insulin Activation of Glucose Uptake both in Vivo and in Vitro
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2084 - 2089.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. van Exel, J. Gussekloo, A. J.M. de Craen, M. Frolich, A. Bootsma-van der Wiel, and R. G.J. Westendorp
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes : The Leiden 85-Plus Study
Diabetes, April 1, 2002; 51(4): 1088 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. S. Hardin, A. Leblanc, G. Marshall, and D. K. Seilheimer
Mechanisms of insulin resistance in cystic fibrosis
Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1022 - E1028.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. B. Savage, C. P. Sewter, E. S. Klenk, D. G. Segal, A. Vidal-Puig, R. V. Considine, and S. O'Rahilly
Resistin / Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator-Activated Receptor-{gamma} Action in Humans
Diabetes, October 1, 2001; 50(10): 2199 - 2202.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Fruhbeck, J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E827 - E847.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E745 - E751.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. M. Bruun, S. B. Pedersen, and B. Richelsen
Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1267 - 1273.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
D. Le Roith and Y. Zick
Recent Advances in Our Understanding of Insulin Action and Insulin Resistance
Diabetes Care, March 1, 2001; 24(3): 588 - 597.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
M. Blüher, J. Kratzsch, and R. Paschke
Plasma Levels of Tumor Necrosis Factor-{alpha}, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose Tolerance
Diabetes Care, February 1, 2001; 24(2): 328 - 334.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring
Pathophysiology and Pharmacological Treatment of Insulin Resistance
Endocr. Rev., December 1, 2000; 21(6): 585 - 618.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
J. A. Engelman, A. H. Berg, R. Y. Lewis, M. P. Lisanti, and P. E. Scherer
Tumor Necrosis Factor {alpha}-Mediated Insulin Resistance, but Not Dedifferentiation, Is Abrogated by MEK1/2 Inhibitors in 3T3-L1 Adipocytes
Mol. Endocrinol., October 1, 2000; 14(10): 1557 - 1569.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, and B. Hainque
Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3338 - 3342.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Rönnemaa, K. Pulkki, and J. Kaprio
Serum Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Is Elevated in Obesity But Is Not Related to Insulin Sensitivity: A Study in Identical Twins Discordant for Obesity
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2728 - 2732.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Paquot, M. J. Castillo, P. J. Lefèbvre, and A. J. Scheen
No Increased Insulin Sensitivity after a Single Intravenous Administration of a Recombinant Human Tumor Necrosis Factor Receptor: Fc Fusion Protein in Obese Insulin-Resistant Patients
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1316 - 1319.
[Abstract] [Full Text]

Home page
 Exp. Biol. Med.Home page
C. Qi and P. H. Pekala
Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance in Adipocytes
Experimental Biology and Medicine, February 1, 2000; 223(2): 128 - 135.
[Abstract] [Full Text]

Home page
 NEJMHome page
P. R. Shepherd and B. B. Kahn
Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus
N. Engl. J. Med., July 22, 1999; 341(4): 248 - 257.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Zinman, A. J. G. Hanley, S. B. Harris, J. Kwan, and I. G. Fantus
Circulating Tumor Necrosis Factor-{alpha} Concentrations in a Native Canadian Population with High Rates of Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 272 - 278.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
K. T. Uysal, S. M. Wiesbrock, and G. S. Hotamisligil
Functional Analysis of Tumor Necrosis Factor (TNF) Receptors in TNF-{alpha}-Mediated Insulin Resistance in Genetic Obesity
Endocrinology, December 1, 1998; 139(12): 4832 - 4838.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. L. Morin, E. C. Gayles, D. A. Podolin, Y. Wei, M. Xu, and M. J. Pagliassotti
Adipose Tissue-Derived Tumor Necrosis Factor Activity Correlates with Fat Cell Size But Not Insulin Action in Aging Rats
Endocrinology, December 1, 1998; 139(12): 4998 - 5005.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Paolisso, M. R. Rizzo, G. Mazziotti, M. R. Tagliamonte, A. Gambardella, M. Rotondi, C. Carella, D. Giugliano, M. Varricchio, and F. D'Onofrio
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha
Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E294 - E299.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Mohamed-Ali, S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-{alpha}, in Vivo
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4196 - 4200.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. L. Morin, R. H. Eckel, T. Marcel, and M. J. Pagliassotti
High Fat Diets Elevate Adipose Tissue-Derived Tumor Necrosis Factor-{alpha} Activity
Endocrinology, November 1, 1997; 138(11): 4665 - 4671.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
P. A. Kern
Potential Role of TNFalpha and Lipoprotein Lipase as Candidate Genes for Obesity
J. Nutr., September 1, 1997; 127(9): 1917 - 1917.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
C. Furnsinn, S. Neschen, O. Wagner, M. Roden, M. Bisschop, and W. Waldhausl
Acute and Chronic Exposure to Tumor Necrosis Factor-{alpha} Fails to Affect Insulin-Stimulated Glucose Metabolism of Isolated Rat Soleus Muscle
Endocrinology, July 1, 1997; 138(7): 2674 - 2679.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. J Krentz
Fortnightly Review: Insulin resistance
BMJ, November 30, 1996; 313(7069): 1385 - 1389.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. Moldes, F. Lasnier, X. Gauthereau, C. Klein, J. Pairault, B. Feve, and A.-M. Chambaut-Guerin
Tumor Necrosis Factor-alpha -induced Adipose-related Protein (TIARP), a Cell-surface Protein That Is Highly Induced by Tumor Necrosis Factor-alpha and Adipose Conversion
J. Biol. Chem., August 31, 2001; 276(36): 33938 - 33946.
[Abstract]